Your cart is empty.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
 |
Männedorf, Switzerland, December 9, 2010 – Tecan has launched a Gas Control Module (GCM™) for its Infinite 200 PRO multimode microplate reader, creating one of the most comprehensive solutions on the market for cell-based assays. Variations in environmental conditions can lead to inconsistent and unreliable data for cell-based optical studies, due changes in the pH and color of the media during incubation. By offering precise regulation of oxygen or carbon dioxide levels within the reader chamber, the GCM provides a more stable culture environment over time. This makes it ideally suited to in vitro investigation of eukaryotic cell lines, achieving better cell viability and allowing the duration of cell-based experiments to be extended without adversely affecting results.
The GCM also ensures greater biological relevance for a wide range of studies, by allowing assays to be performed under hypoxic or physiological conditions. This will extend the experimental window of microplate-based investigations using anaerobic or facultative anaerobic bacteria, allowing incubation within the reader chamber. It also allows the Infinite 200 PRO to be used for a range of biomedical studies, providing researchers with a simple mechanism for studying cell behavior under changing environmental conditions, mimicking events such as ischemia or oxidative shock for in vitro investigation.
To find out more on Tecan’s Infinite 200 PRO, visit http://www.tecan.com/infinite200
For more information please contact
Tecan Trading AG
Tanja Sager
Seestrasse 103
CH-8708 Männedorf
Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. As an original equipment manufacturer, Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2009, Tecan generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN CH0012100191).